BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34496447)

  • 1. Societal costs of subclinical depressive symptoms in Dutch adolescents: a cost-of-illness study.
    Bodden DHM; van den Heuvel MWH; Engels RCME; Dirksen CD
    J Child Psychol Psychiatry; 2022 Jul; 63(7):771-780. PubMed ID: 34496447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Societal burden of adolescent depression, an overview and cost-of-illness study.
    Bodden DHM; Stikkelbroek Y; Dirksen CD
    J Affect Disord; 2018 Dec; 241():256-262. PubMed ID: 30138810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complaint-Directed Mini-Interventions for Depressive Symptoms: A Health Economic Evaluation of Unguided Web-Based Self-Help Interventions Based on a Randomized Controlled Trial.
    Wijnen BF; Lokman S; Leone S; Evers SM; Smit F
    J Med Internet Res; 2018 Oct; 20(10):e10455. PubMed ID: 30274958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of depression in South Korea.
    Chang SM; Hong JP; Cho MJ
    Soc Psychiatry Psychiatr Epidemiol; 2012 May; 47(5):683-9. PubMed ID: 21526429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Web-Based Computer-Tailored Alcohol Prevention Program for Adolescents: Cost-Effectiveness and Intersectoral Costs and Benefits.
    Drost RM; Paulus AT; Jander AF; Mercken L; de Vries H; Ruwaard D; Evers SM
    J Med Internet Res; 2016 Apr; 18(4):e93. PubMed ID: 27103154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluation of an Internet-Based Preventive Cognitive Therapy With Minimal Therapist Support for Recurrent Depression: Randomized Controlled Trial.
    Klein NS; Bockting CL; Wijnen B; Kok GD; van Valen E; Riper H; Cuijpers P; Dekker J; van der Heiden C; Burger H; Smit F
    J Med Internet Res; 2018 Nov; 20(11):e10437. PubMed ID: 30478021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial.
    van Dijk SE; Pols AD; Adriaanse MC; Bosmans JE; Elders PJ; van Marwijk HW; van Tulder MW
    BMC Psychiatry; 2013 May; 13():128. PubMed ID: 23651614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of nurse-led self-help for recurrent depression in the primary care setting: design of a pragmatic randomised controlled trial.
    Biesheuvel-Leliefeld KE; Kersten SM; van der Horst HE; van Schaik A; Bockting CL; Bosmans JE; Smit F; van Marwijk HW
    BMC Psychiatry; 2012 Jun; 12():59. PubMed ID: 22677092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dismantling the relative effectiveness of core components of cognitive behavioural therapy in preventing depression in adolescents: protocol of a cluster randomized microtrial.
    van den Heuvel MWH; Bodden DHM; Moerbeek M; Smit F; Engels RCME
    BMC Psychiatry; 2019 Jun; 19(1):200. PubMed ID: 31248384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of a dietary intervention for adults with major depression (the "SMILES" trial).
    Chatterton ML; Mihalopoulos C; O'Neil A; Itsiopoulos C; Opie R; Castle D; Dash S; Brazionis L; Berk M; Jacka F
    BMC Public Health; 2018 May; 18(1):599. PubMed ID: 29783983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.
    Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P
    Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness, Cost-effectiveness, and Cost-Utility of a Digital Alcohol Moderation Intervention for Cancer Survivors: Health Economic Evaluation and Outcomes of a Pragmatic Randomized Controlled Trial.
    Mujcic A; Blankers M; Boon B; Berman AH; Riper H; van Laar M; Engels R
    J Med Internet Res; 2022 Feb; 24(2):e30095. PubMed ID: 35103605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial.
    de Graaf LE; Gerhards SA; Evers SM; Arntz A; Riper H; Severens JL; Widdershoven G; Metsemakers JF; Huibers MJ
    BMC Public Health; 2008 Jun; 8():224. PubMed ID: 18590518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An economic evaluation of an augmented cognitive behavioural intervention vs. computerized cognitive training for post-stroke depressive symptoms.
    van Eeden M; Kootker JA; Evers SM; van Heugten CM; Geurts AC; van Mastrigt GA
    BMC Neurol; 2015 Dec; 15():266. PubMed ID: 26715040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blended vs. face-to-face cognitive behavioural treatment for major depression in specialized mental health care: study protocol of a randomized controlled cost-effectiveness trial.
    Kooistra LC; Wiersma JE; Ruwaard J; van Oppen P; Smit F; Lokkerbol J; Cuijpers P; Riper H
    BMC Psychiatry; 2014 Oct; 14():290. PubMed ID: 25326035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost-effectiveness of a guided Internet- and mobile-based intervention for the indicated prevention of major depression in patients with chronic back pain-study protocol of the PROD-BP multicenter pragmatic RCT.
    Sander L; Paganini S; Lin J; Schlicker S; Ebert DD; Buntrock C; Baumeister H
    BMC Psychiatry; 2017 Jan; 17(1):36. PubMed ID: 28109247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.
    Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O
    BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a transdiagnostic individually tailored Internet-based and mobile-supported intervention for the indicated prevention of depression and anxiety (ICare Prevent) in Dutch college students: study protocol for a randomised controlled trial.
    Bolinski F; Kleiboer A; Karyotaki E; Bosmans JE; Zarski AC; Weisel KK; Ebert DD; Jacobi C; Cuijpers P; Riper H
    Trials; 2018 Feb; 19(1):118. PubMed ID: 29458407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.